Actively Recruiting
Effectiveness of Trauma Treatment in Norwegian Specialist Health Care Services Comparing EMDR and Cognitive Therapy for PTSD
Led by Vestre Viken Hospital Trust · Updated on 2024-11-15
270
Participants Needed
1
Research Sites
113 weeks
Total Duration
On this page
Sponsors
V
Vestre Viken Hospital Trust
Lead Sponsor
N
Norwegian Center for Violence and Traumatic Stress Studies
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are comparing two main therapies for post-traumatic stress disorder (PTSD) called eye movement desensitization and reprocessing (EMDR) and cognitive therapy for PTSD (CT-PTSD). This large, long-term study aims to understand how well these treatments work in Norwegian specialist health care. The study will look at how these therapies affect PTSD symptoms, other related disorders, complex PTSD symptoms, and how patients function after treatment. It will also explore the role of the therapeutic relationship and long-term effects over time. Participants will be randomly assigned to receive either EMDR or CT-PTSD, each following a set treatment plan of up to 24 weekly therapy sessions. If no clear improvement is seen after 10 sessions, treatment may be stopped. EMDR focuses on processing trauma memories while using bilateral stimulation to reduce distress, while CT-PTSD uses cognitive techniques like restructuring thoughts and controlled exposure to trauma memories. Both therapies are provided in line with patient treatment goals. During the study, patients will complete digital questionnaires before treatment and after each therapy session to report symptoms of PTSD, depression, anxiety, psychosis, substance use, and functional outcomes. Researchers will monitor changes in PTSD symptoms from the start to the end of treatment at 24 weeks, with follow-ups at 3, 6, and 12 months. They will also assess effects on comorbid illnesses, functional outcomes, and the quality of the therapeutic alliance. The study lasts over a year, including treatment and follow-up assessments.
CONDITIONS
Brief Title
Effectiveness of Trauma Treatment in the Specialist Health Care Services
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Diagnosed with PTSD based on the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) with a total score of 23 or higher
You will not qualify if you...
- Insufficient mastery of the Norwegian language
- Severe intellectual impairment with an estimated IQ of 70 or less
- Acute comorbid psychiatric illnesses that require other prioritized treatments such as hospitalization
- History of prior EMDR or cognitive therapy for PTSD treatment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 24 weeks, with treatment possibly ending after 10 sessions if no improvement is seen
Participants receive psychotherapy with either Eye Movement Desensitization and Reprocessing (EMDR) or Cognitive Therapy for PTSD (CT-PTSD) in weekly sessions to reduce PTSD symptoms.
Weekly visits for up to 24 weeks
Duration - Up to 12 months after treatment completion
Participants complete follow-up assessments to monitor PTSD symptoms and comorbid conditions after treatment ends.
3 visits at 3, 6, and 12 months post-treatment
Trial Site Locations
Total: 1 location
1
Vestre Viken Health Trust
Drammen, Akershus, Norway, 3004
Actively Recruiting
Research Team
S
Susie Fu, PhD, Cand. Psychol.
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here